FIELD: pharmaceuticals.
SUBSTANCE: group of inventions refers to pharmaceutical compositions used in the treatment of extensive purulent-necrotic post-traumatic, postoperative wounds. Compositions for topical or topical application according to the invention contain 0.1–5 % by weight of dioxidine, a hydrophilic base and at least one target additive selected from the group: 0.5–6.5 % by weight anesthetic, 0.05–16 % by weight of a complex of proteolytic enzymes, 0.001–5 % by weight of a synthetic antibacterial agent that reduces the resistance of microorganisms, 0.5–5 % by weight of an antibiotic, 0.05–12.5 % by weight of synthetic immunomodulator, dimexidum, stimulator of reparative processes, antimycotic.
EFFECT: invented combined composition creates optimal conditions for shortening the periods of systemic antimicrobial and antifungal therapy, allows to accelerate the healing process, improve the conditions for wound healing.
19 cl, 43 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMBINED COMPOSITION FOR LOCAL AND EXTERNAL USE ON BASIS OF BACTERIOLYTIC AND PROTEOLYTIC COMPLEX OF ENZYMES | 2016 |
|
RU2655808C2 |
PHARMACEUTICAL COMBINED COMPOSITION FOR THE TREATMENT OF PURULENT WOUNDS ON THE BASIS OF FLUOROQUINOLONS (OPTIONS) | 2016 |
|
RU2682171C2 |
ANTIBACTERIAL AND NECROLYTIC EXTERNAL AND LOCAL LISOAMIDASE PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2367457C2 |
STABLE COMBINED PHARMACEUTICAL COMPOSITION OF DIOXIDINE AND ANESTHETICS | 2017 |
|
RU2733714C2 |
LOCAL AND EXTERNAL PHARMACEUTICAL PRODUCT BASED OF LOW MOLECULAR INTERFERON INDUCER | 2007 |
|
RU2353354C1 |
PHARMACEUTICAL PREPARATION FOR LOCAL AND EXTERNAL USE, BASED ON LOW-MOLECULAR INTERFERON INDUCER | 2007 |
|
RU2348400C1 |
ANTIBACTERIAL AND NECROLYTIC LOCAL LISOAMIDASE PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2367469C2 |
ANTIBACTERIAL AND NECROLYTIC LOCAL PHARMACEUTICAL COMPOSITION | 2007 |
|
RU2367456C2 |
AGENT FOR PYOINFLAMMATORY PROCESSES IN SOFT TISSUES AND MUCOUS MEMBRANES | 2017 |
|
RU2646462C1 |
CYCLOPHERONE-BASED PHARMACEUTICAL COMPOSITION OF LOCAL OR EXTERNAL APPLICATION FOR TREATMENT OF PURULENT-DESTRUCTIVE AFFECTION OF MUCOUS MEMBRANE AND SKIN, GENERAL-SYSTEM DISEASES IN CASE OF IMMUNODEFICIENCY CONDITIONS (VERSIONS) | 2008 |
|
RU2414221C2 |
Authors
Dates
2018-09-25—Published
2016-10-11—Filed